<DOC>
	<DOC>NCT00980876</DOC>
	<brief_summary>The objective of this study is to compare the efficacy and safety profiles of the test product containing 2 mg/mL ciprofloxacin hydrochloride associated with 10 mg/mL of hydrocortisone with the reference product Cipro HCÂ®, in patients with acute otitis externa.</brief_summary>
	<brief_title>A Comparative Study Between Two Formulations of the Ciprofloxacin Hydrochloride + Hydrocortisone Otic Suspension</brief_title>
	<detailed_description>Phase III, non inferiority, multicentric, controlled, single blind, parallel-group, randomized study. Population: 224 patients with external otitis , men and women aged between 1 - 70 years. Primary endpoint: The primary endpoint of this study is the elimination of pain, swelling and otorrhea (cure). Secondary endpoint: The endpoint will be the identification of the side effects of medication use.</detailed_description>
	<mesh_term>Otitis</mesh_term>
	<mesh_term>Otitis Externa</mesh_term>
	<mesh_term>Ciprofloxacin</mesh_term>
	<mesh_term>Ciprofloxacin, hydrocortisone drug combination</mesh_term>
	<mesh_term>Hydrocortisone 17-butyrate 21-propionate</mesh_term>
	<mesh_term>Cortisol succinate</mesh_term>
	<mesh_term>Hydrocortisone acetate</mesh_term>
	<mesh_term>Hydrocortisone</mesh_term>
	<criteria>Informed of the nature of the study and given written informed consent; Patients with acute otitis externa; Intact tympanic membrane. Known allergy or sensitivity to Ciprofloxacin Hydrochloride and Hydrocortisone; Patient has the tympanic membrane not intact; Diabetes Bilateral Acute Otitis Externa; Pregnant or lactating patients; Overt fungal Acute Otitis Externa; Other diseases of the ear Current Infection requiring systemic antimicrobial therapy. Current enrollment in an investigational drug or device study or participation in such a study within 30 days of entry into this study.</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2012</verification_date>
</DOC>